Abstract
Objective Turoctocog alfa is a recombinant factor VIII (rFVIII) for the prevention and treatment of bleeding in patients with hemophilia A, including those undergoing surgery and invasive medical procedures. This in vitro study evaluated the physical and chemical stability of turoctocog alfa during continuous infusion (CI) over 24 hours at 30°C. Materials and Methods The study was performed at 30°C ( ± 2°C). A CI system with pump speed set at either 0.6 or 1.5 mL/h was used to evaluate the stability of three turoctocog alfa strengths (500, 1,000, and 3,000 IU), equating to doses of 1.1 to 16.1 IU/h per kilogram of body weight. The following parameters were evaluated at selected time points between 0 and 24 hours: appearance of solution, clarity, pH, potency, purity, content, total high molecular weight proteins (HMWPs), and oxidized rFVIII. Results The mean potency of turoctocog alfa was maintained within the predefined acceptance criteria during CI for both pump speeds with all three strengths at 6, 12, or 24 hours (500 IU: ≥484 IU/vial; 1,000 IU: ≥1,014 IU/vial; and 3,000 IU: ≥3,029 IU/vial). Furthermore, the appearance of solution, clarity, pH, purity, content of turoctocog alfa, total HMWP, and oxidized forms were also w...Continue Reading
References
Sep 21, 2000·British Journal of Haematology·A Batorova, U Martinowitz
Nov 15, 2003·Blood·J Michael SoucieGilbert C White
Apr 1, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Maximilian FernandezGerald Spotts
Mar 21, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·U MartinowitzA Lubetsky
Sep 22, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·S Revel-VilkM L Rand
Apr 20, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·H Takedani
Apr 26, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·A BatorovaUNKNOWN European Haemophilia Treatment Standardisation Board
Apr 26, 2012·British Journal of Haematology·P Vince JenkinsJames S O'Donnell
Jul 11, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·A SrivastavaUNKNOWN Treatment Guidelines Working Group on Behalf of The World Federation Of Hemophilia
Oct 3, 2012·Vox Sanguinis·Y ChevalierC Negrier
May 7, 2013·Haematologica·Séverine HenrardCedric Hermans
May 8, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·S R LentzU Martinowitz
May 9, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·R KulkarniE Santagostino
Oct 3, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·E SantagostinoI Matytsina
Dec 3, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·K MeijerP C Schinco
Dec 31, 2014·Blood Research·Ye Jee ShimShin Young Hyun
Aug 15, 2015·Hämostaseologie·A TiedeJ Oldenburg
Aug 24, 2017·BMC Musculoskeletal Disorders·Young Shil ParkKang-Il Kim
Sep 6, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·P A HolmeA Batorova
Feb 1, 2018·International Journal of Hematology·Masahiro TakeyamaMidori Shima